Status:
COMPLETED
Analysis of Mortality of Critically Ill Patients With COVID-19
Lead Sponsor:
Hospital Universitario Getafe
Collaborating Sponsors:
Hospital Universitario del Tajo
Puerta de Hierro University Hospital
Conditions:
COVID-19
Critical Illness
Eligibility:
All Genders
18-99 years
Brief Summary
The recent pandemic of the COVID-19 disease has caused a national health emergency due to its severity and the clinical and social consequences of the disease. Crude mortality in Spain is 9.2%. Howeve...
Detailed Description
Introduction The World Health Organization (WHO) has recently declared SARS-CoV-2 (COVID-19) disease as an international alarm public health emergency. This ongoing pandemic of COVID-19 disease is dev...
Eligibility Criteria
Inclusion
- patients over 18 years of age who are admitted to the ICU with the confirmed diagnosis of COVID-19.
Exclusion
- none
Key Trial Info
Start Date :
February 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 8 2021
Estimated Enrollment :
868 Patients enrolled
Trial Details
Trial ID
NCT04379258
Start Date
February 8 2021
End Date
February 8 2021
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Getafe
Getafe, Madrid, Spain, 28905